Podcasts about cancergrace

Dr. Rana McKay discusses why it's crucial to get a prostate cancer screening.

Dr. Vernon Sondak looks at the recent improvements in treatment of metastatic melanoma, including the Relativity 047 trial.

Dr. Medhavi Gupta discusses how common breast cancer is, and why it is crucial to get screened.

Dr. Medhavi Gupta discusses mammograms, ultrasounds, and MRIs for breast cancer screening.

Dr. Medhavi Gupta examines the steps a patient could go through after an abnormality is found on a breast cancer screening.

Dr. Devika Das examines the importance of patient centered care, including safety throughout the process, and equitable care for all.

Dr. Medhavi Gupta discusses symptoms that may be seen in patients with breast cancer.

Dr. Devika Das discusses comprehensive care in lung cancer, and who is involved from screening to treatment.

Dr. Medhavi Gupta examines how treatment can look for patients diagnosed with breast cancer.

Dr. Devika Das talks about goals for lung cancer advocacy, including broader testing.

Dr. Medhavi Gupta reiterates the importance of breast cancer screening in detection and treatment.

Dr. Tejas Patil discusses when to utilize molecular testing in patients with NSCLC. For full video visit cancerGRACE.org.

Dr. Melina Marmarelis discusses the treatment of peritoneal mesothelioma.

Dr. Melina Marmarelis discusses ways mesothelioma may be treated in the future.

Dr. Melina Marmarelis discusses the use of chemotherapy with and without immunotherapy in patients with mesothelioma.

Dr. Melina Marmarelis discusses the various surgical options for patients with mesothelioma.

Dr. Melina Marmarelis discusses how doctors diagnose mesothelioma and determine the stage of the disease.

Dr. Melina Marmarelis discusses the epidemiology of mesothelioma.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the role telemedicine can play in cancer treatment.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the effectiveness of liquid biopsies at detecting TKI resistance for fusions such as ALK, ROS1, and RET.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the coverage, cost, and standard of care for liquid and tissue biopsy monitoring.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss whether circulating tumor DNA testing will replace marker testing.

Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Meredith McKean discusses molecular profiling and driver mutations in patients with melanoma.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Dr. Meredith McKean discusses the importance of skin cancer screenings. Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Meredith McKean discusses molecular profiling and driver mutations in patients with melanoma.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Roman Groisberg discusses Leptomeningeal disease and brain metastases in melanoma patients.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Dr. Douglas Johnson discusses the potential toxicities that are associated with immunotherapy in melanoma patients.Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Dr. Meredith McKean discusses neoadjuvant treatment for melanoma patients.Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Meredith McKean discusses molecular profiling and driver mutations in patients with melanoma.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Dr. Douglas Johnson discusses treatment options for patients with metastatic melanoma.Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Roman Groisberg discusses options for adjuvant treatment in patients with melanoma.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Dr. Johathan Riess joins GRACE to discuss alternatives to radiation for patients with brain metastases.

Dr. Caroline McCoach joins GRACE to discuss optimal treatment for patients with advanced non small cell lung cancer and a BRAF-V600 mutation.

Dr. Howard Jack West discusses ALK Rearrangement-Positive NSCLC and if ALK inhibitors treat and prevent brain metastases?

Dr. Heather Wakelee discusses whether blood-based mutation-testing can help shape treatment decisions for advanced NSCLC.

Dr. Heather Wakelee discusses which patients should receive consolidation immunotherapy after chemo radiation for stage 3 unresectable non small cell lung cancer.

Dr. H. Jack West discusses if local therapies improve outcomes for patients with stage IV NSCLC who have a very good response to first line systemic therapy

Dr. Joel Neal discusses pre-operative immunotherapy and if it could improve outcomes in early stage NSCLC. Why trials are looking at this approach.

Dr. Millie Das discusses the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced nonsquamous NSCLC today.

Dr. Dr. Joel Neal discusses patients with an EGFR mutation positive advanced non small cell lung cancer and if they can benefit from immunotherapy.

Dr. Caroline McCoach discusses ALK Rearrangement-Positive NSCLC and the leading first line treatment options for advanced NSCLC harboring an ALK rearrangement today

Dr. Joel Neal discusses Small Cell Lung Cancer and whether or not immunotherapy can help patients with small cell lung cancer

Dr. Matthew Gubens discusses Targeted therapies in NSCLC PD-L1 Expression and the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today

Dr. Jonathan Reiss discusses EGFR Mutation and the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today

Dr H. Jack West discusses Immunotherapy in NSCLC, and which patients with advanced NSCLC are good candidates for first line immunotherapy alone today?

Dr. Jonathan Reiss discusses the current standard of care for patients with extensive stage small cell lung cancer.

Dr. Millie Das discusses leading treatment options for patients with non small cell lung cancer and hugh tumor PDL1 expression

Dr. Millie Das discusses treatment options for patients with advanced non small cell lung cancer and a HER2-ERBB2 mutation.

Dr. Stephen Liu, member of the GRACE faculty, discusses leading treatment options for patients with negative tumor pdl-1 in non small cell lung cancer. For more information visit www.cancerGRACE.org

Dr. Stephen Liu, member of the GRACE faculty, discusses immunotherapy for small cell lung cancer. For more information visit www.cancerGRACE.org

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer for RET fusions.For more information visit www.cancerGRACE.org

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer with a MET mutation. for more information visit www.cancerGRACE.org